ADIPOQ, adiponectin, C1Q and collagen domain containing, 9370
N. diseases: 679; N. variants: 45
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3 | 186843845 | intron variant | G/A | snv | 0.14 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||||||
|
3 | 186843845 | intron variant | G/A | snv | 0.14 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
3 | 186843845 | intron variant | G/A | snv | 0.14 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
3 | 186845325 | intron variant | C/A;G | snv |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
3 | 186841714 | upstream gene variant | G/T | snv |
|
0.700 | 0 | ||||||||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.100 | 0.923 | 13 | 2009 | 2019 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Cardiovascular Diseases | 0.090 | 1.000 | 9 | 2012 | 2019 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Cardiovascular Diseases | 0.070 | 1.000 | 7 | 2012 | 2018 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.060 | 1.000 | 6 | 2009 | 2019 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Cardiovascular Diseases | 0.050 | 0.800 | 5 | 2011 | 2019 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Cardiovascular Diseases | 0.050 | 0.600 | 5 | 2011 | 2018 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Neoplasms | 0.050 | 0.800 | 5 | 2013 | 2015 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Neoplasms | 0.050 | 0.800 | 5 | 2013 | 2015 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Digestive System Diseases; Neoplasms | 0.040 | 0.750 | 4 | 2014 | 2015 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Digestive System Diseases | 0.040 | 1.000 | 4 | 2015 | 2019 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Nutritional and Metabolic Diseases | 0.040 | 1.000 | 4 | 2011 | 2018 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.030 | 0.667 | 3 | 2006 | 2018 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2008 | 2013 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2012 | 2018 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Nervous System Diseases; Cardiovascular Diseases | 0.030 | < 0.001 | 3 | 2006 | 2015 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.030 | 1.000 | 3 | 2013 | 2018 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2008 | 2013 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2014 | 2015 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Musculoskeletal Diseases | 0.020 | 1.000 | 2 | 2019 | 2019 | ||||||||
|
0.597 | 0.720 | 3 | 186853334 | intron variant | G/C;T | snv |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2011 | 2012 |